Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Longitudinal PRO modeling, rather than time-to-worsening censoring, indicated maintained HRQOL and pain outcomes with ...

Artificial intelligence (AI) has become an indispensable tool in Estonian hospitals, aiding both stroke and radiation therapy treatment while saving doctors hours of valuable time. At the same time, ...

Castle Biosciences, Inc. ( CSTL) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2025 Conference Call. As a reminder, ...

Nuvation Bio Inc. (NYSE:NUVB) Q4 2025 Earnings Call Transcript March 3, 2026 Operator: Hello, and welcome to Nuvation Bio’s Fourth Quarter and Full Year 2020 Financial Results and Corporate Update ...

Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT ™) with its innovative RadioGel ® technology, today provided an update on its ongoing efforts to ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Welcome to the Nuvation Bio Fourth Quarter and Full Year 2025 Earnings Conference Call. Earlier today, we released financia ...

Teens and young adults who survive cancer appear to age more quickly than people their same age who have never had the disease, according to new ...

Registered conference attendees may schedule a meeting with Soligenix via the conference scheduling platforms. If you are unable to attend the conferences and would like to schedule a meeting with ...

Clinical performance without compromise At the heart of Rembra is Philips’ newest NanoPanel Precise XD, a high-density detector designed from the outset to work hand-in-hand with AI. It delivers high ...

Radiation therapy is highly effective at killing cancer cells, but it often harms healthy skin around the treatment area, a common side effect experienced by up to 95% of cancer patients undergoing ...